Last reviewed · How we verify
NCT03802500: EDX
Neurophysiological Diagnosis for ICU Septic Shock Patients
trial testing Nerve conduction study in ICU Acquired Weakness in 20 participants. Status unknown.
31 October 2019
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire Vaudois |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 23 January 2019 |
| Primary completion | 31 October 2019 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Nerve conduction study
Conditions studied
- ICU Acquired Weakness — all drugs for ICU Acquired Weakness →
Sponsor
Centre Hospitalier Universitaire Vaudois
Who can join
18 and older, any sex, with ICU Acquired Weakness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients hospitalized in the Intensive Care Unit (ICU) are at risk for developing severe disabilities, physical or cognitive. In particular, ICU-acquired weakness is frequent. The causes of this weakness are multiple and the physiopathology is still not fully understood. Immobilization in bed and sepsis are known risk factors. ICU-acquired weakness has been associated with prolonged mechanical ventilation duration, and increased in ICU and hospital length of stay. It has also been associated with significant decrease in functional capacity and with higher mortality. An early screening using a specific diagnostic protocol could help improving the management of patients suffering from ICU acquired weakness. The aim of this study is to early detect ICU acquired weakness in patients suffering from septic shock and ventilated for more than 72 hours.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03802500
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Nerve conduction study
Trials testing the same drug.
- NCT06002009 — SupraScapular Cuff Study: Assessing the Effects of Size and Type of Rotator Cuff Tear on Suprascapular Nerve Function · recruiting
- NCT05861349 — Median Nerve Stenosis in Carpal Tunnel Syndrome · completed
- NCT05311488 — Early Detection of Neuropathy in ATTRv · completed
- NCT04967144 — Carpal Tunnel Syndrome, Right/Left Judgement · completed
- NCT03045250 — Corneal Confocal Microscopy in Patients With Type 1 Diabetes · NA · withdrawn
Other recruiting trials for ICU Acquired Weakness
Currently open trials in the same condition.
- NCT07167121 — Predictive Validity of the Chelsea Critical Care Physical Assessment Tool (CPAx) for Regaining Autonomy Three Months Aft · recruiting
- NCT07162948 — ICU-Recover Box 2.0, Smart Technology for Home Monitoring of ICU Patients · NA · recruiting
- NCT06592144 — TESTO-TRIAL: Use of Testosterone in Critically Ill Patients · Phase 4 · active not recruiting
- NCT05919940 — Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO ) · NA · recruiting
- NCT05865314 — Optimised Nutritional Therapy and Early Physiotherapy in Long Term ICU Patients (NutriPhyT Trial) · NA · recruiting
Other Centre Hospitalier Universitaire Vaudois trials
Trials by the same sponsor.
- NCT07427511 — SwissNeuroRehab - HDHI · NA · recruiting
- NCT07263438 — Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a · Phase 2 · recruiting
- NCT07139756 — Deciphering the Mechanisms of Central BP Regulation in Patients With PD Associated With Orthostatic Hypotension · not yet recruiting
- NCT07109388 — Comparison of Pericapsular Nerve Group (PENG) Block With a Combined Femoral, Sciatic, Lateral Femoral Cutaneous Nerve Bl · NA · not yet recruiting
- NCT07268378 — Supervision of Clinicians in Oncology by Psycho-oncologists : Evaluation · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03802500 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire Vaudois
- Last refreshed: 4 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03802500.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing